New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
17:14 EDTALXAAlexza's Adasuve FDA approval has several post approval requirements
Alexza has several post-approval requirements, including a large observational clinical trial designed to gather patient safety data based on the real-world use of Adasuve, as well as a clinical program addressing the safety and efficacy of Adasuve in agitated adolescent patients.
News For ALXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
09:07 EDTALXAAlexza Pharmaceuticals and Ferrer expand Adasuve partnership
Alexza Pharmaceuticals announced that they have amended their agreement for ADASUVE. Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America and the Commonwealth of Independent States countries. Ferrer and Alexza have agreed that Ferrer will purchase 2M shares of Alexza common stock for $4.00 per share, thereby becoming the company's largest shareholder. The purchase represents a combination of new investment and consideration for the elimination of certain future potential milestone payments under the agreement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use